Compare Acadia Healthcare Company Inc (ACHC) vs Boston Beer Company Inc (SAM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Acadia Healthcare Company Inc vs Boston Beer Company Inc — how do they compare? Acadia Healthcare Company Inc trades at $30.86 (market cap $2.94B), while Boston Beer Company Inc trades at $178.59 (market cap $1.91B). The key difference: Acadia Healthcare Company Inc is the larger of the two by market cap, and Acadia Healthcare Company Inc is trading nearer its 52-week high, Boston Beer Company Inc nearer its low. Which is the better fit depends on your goals.
| ACHC | SAM | |
|---|---|---|
Market Cap | $2.94B | $1.91B |
Sector | Health | Consumer Staples |
52-Week High | $31.92 | $260.05 |
52-Week Low | $11.68 | $161.08 |
Enterprise Value | $5.45B | $1.78B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.
The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.
Boston Beer (SAM) trades at $183.16, down 0.25% with bearish technical signals. The stock shows mixed fundamentals with a P/E of 22.66 and P/S of 0.99, but negative net income margin of -3.15% and ROE of -7.75%. Recent Q1 2026 earnings missed expectations, though Q3 and Q4 2025 beat estimates. Cash flow improved to $11.56M net in 2025 after a negative 2024. Analyst consensus price target is $233.40 with 74% hold ratings.
SAM faces headwinds from declining volume growth and brand pressure, but maintains strong gross margins at 48.7%. The 27% upside to consensus target offers potential, though execution risks and competitive beverage market pose challenges. Institutional sentiment is cautious with limited buy ratings despite positive cash flow recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Acadia Healthcare Company Inc
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →About Boston Beer Company Inc
Boston Beer is a leader in U.S. high-end malt beverages and adjacent categories, with strong positions in craft beer, hard cider, and hard seltzer. The firm sells an array of flavor variants and package sizes, predominantly centered around four priority brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Its drinks are produced in both company-owned breweries as well as through third-party contract arrangements, and while the company primarily goes to market through independent wholesalers (as mandated by law), it operates a fairly large salesforce to induce demand across the value chain (distributors, retailers, and drinkers). The preponderance of revenue is generated domestically.
Read more on SAM →
